International Medical Lasers (IML), a medical industry specialist in sourcing the surgical devices for the US medical marketplace since 2011, has announced its industry expansion.
Key to this is the launch of a new laser accessory partnership with DEKA Trio featuring a scanner for scar revision and treatment, giving the DEKA Trio laser technology the ability to treat tissue scarring and other medically necessary conditions through CO2 lasers.
IML’s expansion also includes planned educational resources for the US medical community.
IML’s role as a resource for the US surgical market’s global medical technology devices has delivered its new partnership with DEKA Trio, offering a scanner, just cleared by the FDA, for surgical scar revision.
“We take an active role with a consultative and collaborative approach to educating, helping, and providing value by understanding the needs of hospitals, surgeons, and patients,” said IML president and co-founder John Mooney. “Our deep connections with the best in global medical providers and manufacturers have not only secured our newest global medical offering with DEKA Trio, but it has also positioned us to help share the latest in surgical lasers and the techniques that surgeons need.”
Paolo Salvadeo, CEO of DEKA and general manager of its parent company El.En. SpA commented “Partnering with International Medical Lasers resulted in a positive turnaround in our US presence in the laser surgical sector. The US is a beacon to every other country and what is successful there is bound to become a great success internationally. That's why our relationship with IML is so important.”
IML partners with specialists in their respective fields, including medical device companies like Quanta System, DEKA, and Pusen, along with a vast dealer network that helps manufacturers broaden their distribution network and expand into the US market.
Projected by Fortune Business Insights to hold the largest market share by the end of 2035, the growth of the North American surgical lasers market is being driven by expanding healthcare infrastructure, advances in technology, and increasing adoption of surgical lasers due to benefits like reduced blood loss, faster healing, and almost no pain.
As part of IML’s commitment to industry education, the company will launch educational Toolkits, slated for Q4 2023. The Toolkits will provide dealers with relevant and prompt information, increase understanding, and faster confidence. The IML Toolkits are a value-added resource containing in-depth information about products along with strategic advice, training, and support.
